Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Nephrology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Kidney Disease Clinical Trials

A listing of Kidney Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (531) clinical trials

Family Investigation of Nephropathy and Diabetes (F.I.N.D.)

The Family Investigation of Nephropathy and Diabetes (FIND) is a multicenter study designed to identify genetic determinants of diabetic kidney disease. FIND is conducted in eleven centers and in many ethnic groups throughout the United States. Two different strategies are used to localize genes predisposing to kidney disease: a family-based ...

Phase N/A

Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia Hemihypertrophy and Genitourinary Anomalies

If you choose to take part in this study, blood (about 10 teaspoons) will be drawn for genetic testing. The blood may be drawn more than 1 time, depending on how much blood is drawn at the first visit, and if you are available for more blood draws. If this ...

Phase N/A

Prediction of Chronic Renal Disease After Acute Kidney Injury in the Intensive Care Unit

As second objectives, the study aims to: Evaluate the GFR decline in patients who had an underlying chronic kidney disease. Evaluate factors associated with a persistent decreased GFR at day-90. Characterization the clinical and biological phenotype of chronic renal disease in these patients. Evaluate treatments provided to these patients according ...

Phase N/A

Dietary Sodium (DS) Intervention to Reduce Tissue Sodium in Hemodialysis (HD) Patients

Recent studies illustrate that tissue sodium is regulated by immune cells in interstitial fluids such as the skin and muscle. Localized immune responses in these tissues can promote vascular endothelial growth factor secretion to promote lymphatic release of fluid and electrolytes, which has significant implications for blood pressure control and ...

Phase N/A

Pilot: A Comparison of Insulin Sensitivity and Management in Hyperglycemic Patients in the Perioperative Period: ESRD vs. Non-ESRD

The objective of our study is to compare perioperative changes in blood glucose levels following insulin administration (Novolin R human insulin, Novo Nordisk Inc. Plainsboro, NJ) for preoperative hyperglycemia (as defined by blood glucose over 150 mg/dL) in diabetic ESRD patients on hemodialysis vs. diabetic non-ESRD patients without CKD. The ...


Mindfulness and HEP in Dialysis Patients With Depression and Anxiety

Background Dialysis patients are prone to lower increased non-adherence, suicidal behavior, medical comorbidity, mortality and low quality of life. As a result of illness burden in dialysis, treatment is costly and resources for treatment allocation are on the rise. In the United States alone, costs per year of dialysis are ...

Phase N/A

The Kidney and The Brain Study - Assessment of Cognitive Impairment in Advanced CKD

Aims of the proposed research Primary Objective: To test the feasibility of performing serial detailed neurocognitive assessments in patients before during and after the period of commencing RRT for End-Stage Kidney Disease Secondary Objectives: Estimate cross-sectional and longitudinal variability in a novel battery of neurocognitive assessments amongst participants in transition ...

Phase N/A

Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation

Patients who receive renal transplantation at BJH are placed on triple maintenance immunosuppression, which means that patients take 3 types of immunosuppression drugs to suppress their immune system including tacrolimus, mycophenolate (MPA), and prednisone. However, due to the effects of MPA on the gastrointestinal tract, patients often complain of GI ...


Home Hospital for Suddenly Ill Adults

Hospitals are the standard of care for acute illness in the United States, but hospital care is expensive and often unsafe, especially for older individuals. While admitted, 20% suffer delirium, over 5% contract hospital-acquired infections, and most lose functional status that is never regained. Timely access to inpatient care is ...

Phase N/A

Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease

Introduction Management of patients with hepatitis C virus (HCV) related liver disease with concomitant co-morbidity was challenging, especially in the period before the era of new direct-acting antiviral (DAA) agents. With the introduction of DAAs protocols, the therapeutic options were expanded to endorse many patients that were previously assigned as ...